Largest biotech by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech ranked by total debt, at AED 200.5B, ahead of Gilead Sciences (AED 91.6B) and Biogen (AED 23.1B). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenAED 200.5B
Median
AED 2.2B
Combined market value
AED 3.09T
Countries
5
Not ranked
13no total debt on file

Market values as of .

Largest biotech by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareAED 200.5BAED 896.6BAED 1,657.53 1.45% down 34% up United States
2Gilead SciencesGILD · Health CareAED 91.6BAED 764.5BAED 616.39 1.43% down 33% up United States
3BiogenBIIB · Health CareAED 23.1BAED 134.1BAED 907.16 1.51% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareAED 7.9BAED 40BAED 350.69 0.51% down 37% up United States
5QiagenQGEN · Health CareAED 6.1BAED 37.7BAED 182.59 0.07% down 12% up Netherlands
6ModernaMRNA · Health CareAED 2.2BAED 304.6BAED 752.87 0.88% down 755% up United States
7RepligenRGEN · Health CareAED 2BAED 39.2BAED 613.34 2.97% up 5% up United States
8Bio-TechneTECH · Health CareAED 734.5MAED 42BAED 267.08 0.12% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareAED 481.9MAED 17BAED 104.78 0.14% up 88% up United States
10Scholar Rock HoldingSRRK · Health CareAED 366.2MAED 19.8BAED 162.63 1.77% down 14% up United States
11CG OncologyCGON · Health CareAED 11MAED 26.2BAED 293.82 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6727 AED). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech rank first by total debt?

Amgen (AED 200.5B), Gilead Sciences (AED 91.6B) and Biogen (AED 23.1B) are the top three of the 11 biotech ranked by total debt as of 18 Nov 2026, 14:31 UTC.

How many biotech are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 11 biotech ranked by total debt have a combined market value of AED 3.09T as of 18 Nov 2026, 14:31 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.